[1]
Febriza, A. and Kasim, V.N. 2022. Potential effects of hydroxysafflor yellow A on reducing pulmonary inflammation and fibrosis due to SARS-COV2. Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale. 95, 2 (Dec. 2022). DOI:https://doi.org/10.4081/jbr.2022.10572.